Monica Bertagnolli: One-size-fits-all approach to standard blood count tests may miss key health variations
Monica Bertagnolli, Director of the National Institute of Health (NIH), shared a post on LinkedIn:
“NIH-funded research from Mass General Brigham finds that a one-size-fits-all approach to standard blood count tests may miss key health variations.
Since everyone has unique set points, a personalized approach could improve diagnosing certain diseases and conditions, including diabetes, heart disease, and kidney failure, all of which can benefit from early intervention.”
Title: Haematological setpoints are a stable and patient-specific deep phenotype
Authors: Brody H. Foy, Rachel Petherbridge, Maxwell T. Roth, Cindy Zhang, Daniel C. De Souza, Christopher Mow, Hasmukh R. Patel, Chhaya H. Patel, Samantha N. Ho, Evie Lam, Camille E. Powe, Robert P. Hasserjian, Konrad J. Karczewski, Veronica Tozzo and John M. Higgin
Monica Bertagnolli is the Director of the National Institute of Health (NIH), USA. She is the President of Alliance for Clinical Trials In Oncology Foundation. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute. Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology. In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Forum.
For more Updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023